- Home
- GLMD vs JAGX Comparison
GLMD vs JAGX Comparison
Compare GLMD & JAGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GLMD
- JAGX
- Stock Information
- Founded
- GLMD 2000
- JAGX 2013
- Country
- GLMD Israel
- JAGX United States
- Employees
- GLMD N/A
- JAGX N/A
- Industry
- GLMD Biotechnology: Pharmaceutical Preparations
- JAGX Biotechnology: Pharmaceutical Preparations
- Sector
- GLMD Health Care
- JAGX Health Care
- Exchange
- GLMD Nasdaq
- JAGX Nasdaq
- Market Cap
- GLMD 3.0M
- JAGX 3.5M
- IPO Year
- GLMD 2014
- JAGX N/A
- Fundamental
- Price
- GLMD $1.81
- JAGX $2.58
- Analyst Decision
- GLMD Hold
- JAGX Strong Buy
- Analyst Count
- GLMD 1
- JAGX 1
- Target Price
- GLMD N/A
- JAGX $60.00
- AVG Volume (30 Days)
- GLMD 364.3K
- JAGX 90.6K
- Earning Date
- GLMD 05-22-2025
- JAGX 08-12-2025
- Dividend Yield
- GLMD N/A
- JAGX N/A
- EPS Growth
- GLMD N/A
- JAGX N/A
- EPS
- GLMD N/A
- JAGX N/A
- Revenue
- GLMD N/A
- JAGX $11,552,000.00
- Revenue This Year
- GLMD N/A
- JAGX $22.41
- Revenue Next Year
- GLMD N/A
- JAGX $30.00
- P/E Ratio
- GLMD N/A
- JAGX N/A
- Revenue Growth
- GLMD N/A
- JAGX 13.93
- 52 Week Low
- GLMD $1.15
- JAGX $2.43
- 52 Week High
- GLMD $23.80
- JAGX $110.75
- Technical
- Relative Strength Index (RSI)
- GLMD 61.13
- JAGX 28.76
- Support Level
- GLMD $1.63
- JAGX $2.61
- Resistance Level
- GLMD $1.94
- JAGX $3.30
- Average True Range (ATR)
- GLMD 0.12
- JAGX 0.28
- MACD
- GLMD 0.01
- JAGX 0.06
- Stochastic Oscillator
- GLMD 69.77
- JAGX 6.56
About GLMD Galmed Pharmaceuticals Ltd.
Galmed Pharmaceuticals Ltd is a biopharmaceutical company. It focuses on the development of Aramchol. exclusively on developing Aramchol for the treatment of liver disease and were previously developing Aramchol for primary sclerosing cholangitis, PSC, and exploring the feasibility of developing Aramchol for other fibro-inflammatory indications outside of NASH and fibrosis. The company is currently seeking to advance the development of Aramchol for oncological indications outside of NASH and fibrosis.
About JAGX Jaguar Health Inc.
Jaguar Health Inc is a commercial-stage pharmaceuticals company focused on developing novel, plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with GI distress, specifically chronic, debilitating diarrhea. Its product Mytesi is a novel, first-in-class anti-secretory agent which has a basic normalizing effect locally on the gut, and this mechanism of action has the potential to benefit multiple disorders. It has two reportable segments namely human health and animal health. The company generates the majority of its revenue from the Human Health segment.